Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,599,557

« Back to Dashboard

Summary for Patent: 5,599,557

Title: Stable hydrated cephalosporin dry powder for oral suspension formulation
Abstract:A dry hydrated cephalosporin, e.g. ceftibuten having about 7 to 14% by weight of water, powder formulation, pharmaceutical compositions in the form of an oral suspension dosage form and a method of making the dry powder formulations are disclosed.
Inventor(s): Johnson; Donald A. (Miami Lakes, FL), Wearley; Lorraine (Westfield, NJ), Galeos; Rebecca (Bloomfield, NJ), Sequeira; Joel A. (New York, NY)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:08/325,400
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Process; Dosage form;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,599,557

PCT Information
PCT FiledApril 30, 1993PCT Application Number:PCT/US93/03856
PCT Publication Date:November 11, 1993PCT Publication Number: WO93/21923

International Patent Family for Patent: 5,599,557

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Czech Republic283428► Subscribe
Germany69309052► Subscribe
Denmark0642344► Subscribe
Estonia03039► Subscribe
European Patent Office0642344► Subscribe
Spain2099438► Subscribe
Finland945081► Subscribe
Greece3023516► Subscribe
Hong Kong1002407► Subscribe
Hungary9403108► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Queensland Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: